BDBM50191132 CHEMBL438092::sodium (S)-2-(3-((2-(4,5-diphenyloxazol-2-yl)pyrrolidin-1-yl)methyl)phenoxy)acetate

SMILES [O-]C(=O)COc1cccc(CN2CCC[C@H]2c2nc(c(o2)-c2ccccc2)-c2ccccc2)c1

InChI Key InChIKey=WVTUDMXKOFCUFN-UHFFFAOYSA-M

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50191132   

TargetProstacyclin receptor(Human)
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50191132(sodium (S)-2-(3-((2-(4,5-diphenyloxazol-2-yl)pyrro...)
Affinity DataIC50: 58nMAssay Description:Agonist activity at human PGI2 receptor assessed as inhibition of ADP-induced platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetProstacyclin receptor(Rat)
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50191132(sodium (S)-2-(3-((2-(4,5-diphenyloxazol-2-yl)pyrro...)
Affinity DataIC50: 1.00E+4nMAssay Description:Agonist activity at rat PGI2 receptor assessed as inhibition of ADP-induced platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed